M. Docteur TOMASZ SZAFRANSKI
Diplômes
🎓 DES & spécialité ordinale
- Rhumatologie (SM)
🎓 Diplômes
- Diplôme éq d'un pays de l'EEE profession Médecin
📝 Autres formations
- DEES Rhumatologie
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieu de consultation
CABINET DU DR TOMASZ SZAFRANSKI
CLINIQUE CONTI — 3 CHEMIN DES 3 SOURCES, 95290 L'Isle-Adam
☎ 0826968968Libéral© OpenStreetMap
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment
Therapeutic advances in psychopharmacology · 2018
Lire l'abstract Crossref ↓
Wilson’s disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy.
- 2Treatment of depression in first episode of schizophrenia: results from EUFEST
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2012
📚 21 citations🩺 Clinique - 3Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment
Journal of psychopharmacology (Oxford, England) · 2006
📚 14 citationsLire l'abstract Crossref ↓
Electroencephalogram (EEG) slowing is associated with clozapine side effects, e.g., sedation, and may predict treatment response during clozapine treatment. As olanzapine and clozapine share many pharmacological properties, we investigated whether EEG slowing during olanzapine treatment was related to therapy outcome and sleepiness in patients with schizophrenia. Participants were age- and gender-matched schizophrenic patients treated with olanzapine ( n 54), receiving no pharmacological treatment ( n 54), or cotreated with olanzapine and some other psychotropic drug ( n 38). Their EEG recordings were assessed visually by the same rater blind to clinical data. The EEG scores were categorized using standardized forms. Patients with a poor treatment response did not differ significantly from those with a good response to treatment either in EEG patterns or in frequency of sleepiness. Olanzapine treatment was associated with increased rates of slow (70.4% vs. 22.3%) and sharp waves (22.2% vs. 7.4%), as well as of paroxysmal slow wave discharges (14.8% vs. 1.9%), but did not induce spike- or sharp-slow-wave complexes. Cotreatment with another antipsychotic further increased EEG abnormalities, whereas benzodiazepine administration diminished the olanzapine-induced EEG changes. The results show that olanzapine inducing both slow and sharp waves, as well as paroxysmal discharges, has a strong impact on EEG. However, as no spike- or sharp-slow-wave complexes were observed, the risk of epileptic seizure during olanzapine treatment can be regarded as low, as long as olanzapine is not combined with some other antipsychotic.
Publications scientifiques (15) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal9
▼
Transversal9
▼- Oxidative Stress and Psychiatric Symptoms in Wilson's Disease
International journal of molecular sciences · 2025 · Journal Article
Gromadzka G, Karpińska A, Szafrański TK, Litwin T
📚 1 cit. - Letter to the Editor. The Polish standard of teleconsultation in psychiatry
Psychiatria polska · 2021 · Letter
Krzystanek M, Matuszczyk M, Przybyło J, Dudek D, et al.
- Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment
Therapeutic advances in psychopharmacology · 2018 · Journal Article
Litwin T, Dusek P, Szafrański T, Dzieżyc K, et al.
📚 93 cit.🎯 RCR 5.96🔬→🩺 Translationnel - [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions]
Psychiatria polska · 2014 · Journal Article
Szafrański T
📚 1 cit.🩺 Clinique - [Antipsychotics in clinical practice. The refractory schizophrenic patients treatment]
Psychiatria polska · 2008 · Journal Article
Meder J, Tyszkowska M, Jarema M, Araszkiewicz A, et al.
📚 2 cit. - [Stevens-Johnson syndrome in the literature and authors' own studies]
Medycyna wieku rozwojowego · 2008 · Case Reports
Chłystowska M, Pietruszka-Chmarra A, Szafrański T, Michalak J
📚 2 cit. - [A study on the occurrence of the deletion 22q11.2 in patients affected with a psychiatric disease]
Psychiatria polska · 2007 · Comparative Study
Pawłowska B, Tomankiewicz-Zawadzka A, Ilnicka A, Bogdanowicz J, et al.
📚 3 cit. - Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment
Journal of psychopharmacology (Oxford, England) · 2006 · Journal Article
Wichniak A, Szafranski T, Wierzbicka A, Waliniowska E, et al.
📚 14 cit.🔬→🩺 Translationnel - Side effects after phototherapy implementation in addition to fluoxetine or sertraline treatment: a report of two cases
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2002 · Case Reports
Swiecicki Ł, Szafrański T
📚 3 cit.
Santé mentale / fatigue3
▼
Santé mentale / fatigue3
▼- Recommendations of the Working Group of the Congress on Mental Health and the Agreement for the Implementation of the National Mental Health Programme on systemic changes in adult psychiatric care. Part 1. Checklist for statutory solutions
Psychiatria polska · 2025 · Consensus Statement
Balicki M, Biechowska D, Cechnicki A, Ciuńczyk I, et al.
- [Herbal remedies in depression--state of the art]
Psychiatria polska · 2014 · English Abstract
Szafrański T
📚 9 cit.🔬→🩺 Translationnel - Treatment of depression in first episode of schizophrenia: results from EUFEST
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2012 · Journal Article
Rybakowski JK, Vansteelandt K, Szafranski T, Thys E, et al.
📚 21 cit.🩺 Clinique
Case report / série1
▼
Case report / série1
▼- Psychiatric disturbances as a first clinical symptom of Wilson's disease - case report
Psychiatria polska · 2016 · Case Reports
Litwin T, Dzieżyc K, Karliński M, Szafrański T, et al.
📚 9 cit.
Qualité de vie / PROMs1
▼
Qualité de vie / PROMs1
▼- [The change of quality of life and clinical picture in schizophrenia]
Psychiatria polska · 2002 · English Abstract
Jarema M, Konieczyńska Z, Murawiec S, Szafrański T, et al.
Revue générale1
▼
Revue générale1
▼- [Transcranial Doppler sonography study in schizophrenia--review]
Psychiatria polska · 2011 · Journal Article
Pawlak W, Szafrański T
📚 2 cit.
